52 related articles for article (PubMed ID: 38673919)
1. Potential Diagnostic and Clinical Significance of Selected Genetic Alterations in Glioblastoma.
Tomoszková S; Škarda J; Lipina R
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674026
[TBL] [Abstract][Full Text] [Related]
2. A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools.
Thuy MN; Kam JK; Lee GC; Tao PL; Ling DQ; Cheng M; Goh SK; Papachristos AJ; Shukla L; Wall KL; Smoll NR; Jones JJ; Gikenye N; Soh B; Moffat B; Johnson N; Drummond KJ
J Clin Neurosci; 2015 May; 22(5):785-99. PubMed ID: 25698544
[TBL] [Abstract][Full Text] [Related]
3. D-Loop Mutations as Prognostic Markers in Glioblastoma-A Pilot Study.
Szmyd B; Stanisławska P; Podstawka M; Zaczkowski K; Izbiński PM; Kulczycka-Wojdala D; Stawski R; Wiśniewski K; Janczar K; Braun M; Białasiewicz P; Jaskólski DJ; Bobeff EJ
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673919
[TBL] [Abstract][Full Text] [Related]
4. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.
Nguyen HN; Lie A; Li T; Chowdhury R; Liu F; Ozer B; Wei B; Green RM; Ellingson BM; Wang HJ; Elashoff R; Liau LM; Yong WH; Nghiemphu PL; Cloughesy T; Lai A
Neuro Oncol; 2017 Mar; 19(3):394-404. PubMed ID: 27571882
[TBL] [Abstract][Full Text] [Related]
5. No association of MDM2 SNP309 with risk of glioblastoma and prognosis.
El Hallani S; Marie Y; Idbaih A; Rodero M; Boisselier B; Laigle-Donadey F; Ducray F; Delattre JY; Sanson M
J Neurooncol; 2007 Dec; 85(3):241-4. PubMed ID: 17568997
[TBL] [Abstract][Full Text] [Related]
6. Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients.
Salvati M; Pichierri A; Piccirilli M; Floriana Brunetto GM; D'Elia A; Artizzu S; Santoro F; Arcella A; Giangaspero F; Frati A; Simione L; Santoro A
J Neurosurg; 2012 Aug; 117(2):204-11. PubMed ID: 22655594
[TBL] [Abstract][Full Text] [Related]
7. Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study.
Pinson H; Hallaert G; Van der Meulen J; Dedeurwaerdere F; Vanhauwaert D; Van den Broecke C; Van Dorpe J; Van Roost D; Kalala JP; Boterberg T
J Neurooncol; 2020 Jan; 146(1):55-62. PubMed ID: 31701343
[TBL] [Abstract][Full Text] [Related]
8. Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.
Tabone T; Abuhusain HJ; Nowak AK; ; Erber WN; McDonald KL
J Clin Pathol; 2014 Jul; 67(7):550-5. PubMed ID: 24695838
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial DNA Changes in Respiratory Complex I Genes in Brain Gliomas.
Kozakiewicz P; Grzybowska-Szatkowska L; Ciesielka M; Całka P; Osuchowski J; Szmygin P; Jarosz B; Ostrowska-Leśko M; Dudka J; Tkaczyk-Wlizło A; Ślaska B
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189801
[TBL] [Abstract][Full Text] [Related]
10. Newly Recognized CNS Tumors in the 2021 World Health Organization Classification: Imaging Overview with Histopathologic and Genetic Correlation.
Rigsby RK; Brahmbhatt P; Desai AB; Bathla G; Ebner BA; Gupta V; Vibhute P; Agarwal AK
AJNR Am J Neuroradiol; 2023 Apr; 44(4):367-380. PubMed ID: 36997287
[TBL] [Abstract][Full Text] [Related]
11. The tRNA-Cys-GCA Derived tsRNAs Suppress Tumor Progression of Gliomas via Regulating VAV2.
Ren J; Wu X; Shang FF; Qi Y; Tang Z; Wen C; Cao W; Cheng Q; Tan L; Chen H; Zhou HH; Zou H
Dis Markers; 2022; 2022():8708312. PubMed ID: 36426134
[TBL] [Abstract][Full Text] [Related]
12. Identification of SSBP1 as a ferroptosis-related biomarker of glioblastoma based on a novel mitochondria-related gene risk model and in vitro experiments.
Su J; Li Y; Liu Q; Peng G; Qin C; Li Y
J Transl Med; 2022 Sep; 20(1):440. PubMed ID: 36180956
[TBL] [Abstract][Full Text] [Related]
13. Liquid Biopsy in Glioblastoma.
Ronvaux L; Riva M; Coosemans A; Herzog M; Rommelaere G; Donis N; D'Hondt L; Douxfils J
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884454
[TBL] [Abstract][Full Text] [Related]
14. Liquid biopsy in gliomas: A RANO review and proposals for clinical applications.
Soffietti R; Bettegowda C; Mellinghoff IK; Warren KE; Ahluwalia MS; De Groot JF; Galanis E; Gilbert MR; Jaeckle KA; Le Rhun E; Rudà R; Seoane J; Thon N; Umemura Y; Weller M; van den Bent MJ; Vogelbaum MA; Chang SM; Wen PY
Neuro Oncol; 2022 Jun; 24(6):855-871. PubMed ID: 34999836
[TBL] [Abstract][Full Text] [Related]
15. Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patients.
Izquierdo E; Proszek P; Pericoli G; Temelso S; Clarke M; Carvalho DM; Mackay A; Marshall LV; Carceller F; Hargrave D; Lannering B; Pavelka Z; Bailey S; Entz-Werle N; Grill J; Vassal G; Rodriguez D; Morgan PS; Jaspan T; Mastronuzzi A; Vinci M; Hubank M; Jones C
Neurooncol Adv; 2021; 3(1):vdab013. PubMed ID: 34169282
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
